Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Pharmacotherapy

Does selenium supplementation improve Graves ophthalmopathy?

A recent study of selenium supplementation in patients with mild Graves ophthalmopathy (GO) has demonstrated improvements in associated soft-tissue manifestations of the disease. The findings of this multicenter trial reveal a potential treatment option for the mild form of this vexing disease, which affects the majority of patients with GO.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Bahn, R. S. Graves' ophthalmopathy. N. Engl. J. Med. 362, 726–738 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Marcocci, C. et al. Selenium and the course of mild Graves' orbitopathy. N. Engl. J. Med. 364, 1920–1931 (2011).

    Article  CAS  PubMed  Google Scholar 

  3. Kryukov, G. V., et al. Characterization of mammalian selenoproteomes. Science 300, 1439–1443 (2003).

    Article  CAS  PubMed  Google Scholar 

  4. Puertollano, M. A., Puertollano, E., de Cienfuegos, G. A. & de Pablo, M. A. Dietary antioxidants: immunity and host defense. Curr. Top. Med. Chem. 11, 1752–1766 (2011).

    Article  CAS  PubMed  Google Scholar 

  5. Stoedter, M., Renko, K., Hog, A. & Schomburg, L. Selenium controls the sex-specific immune response and selenoprotein expression during the acute-phase response in mice. Biochem. J. 429, 43–51 (2010).

    Article  CAS  PubMed  Google Scholar 

  6. Windmeier, C. & Gressner, A. M. Pharmacological aspects of pentoxifylline with emphasis on its inhibitory actions on hepatic fibrogenesis. Gen. Pharmacol. 29, 181–196 (1997).

    Article  CAS  PubMed  Google Scholar 

  7. Henstrom, D. K, Lindsay, R. W, Cheney, M. L. & Hadlock, T. A. Surgical treatment of the periocular complex and improvement of quality of life in patients with facial paralysis. Arch. Facial Plast. Surg. 13, 125–128 (2011).

    PubMed  Google Scholar 

  8. European Group on Graves' Orbitopathy (EUGOGO) et al. Outcome of orbital decompression for disfiguring proptosis in patients with Graves' orbitopathy using various surgical procedures. Br. J. Ophthalmol. 93, 1518–1523 (2009).

  9. Elsom, R. et al. Functional markers of selenium status: UK Food Standards Agency workshop report. Br. J. Nutr. 96, 980–984 (2006).

    Article  CAS  PubMed  Google Scholar 

  10. Sayar, K. et al. Dietary selenium and vitamin E intakes alter β-adrenergenic response of L-type Ca-current and β-adrenoceptor-adenylate cyclase coupling in rat heart. J. Nutr. 130, 733–740 (2000).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Terry J. Smith.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Smith, T., Douglas, R. Does selenium supplementation improve Graves ophthalmopathy?. Nat Rev Endocrinol 7, 505–506 (2011). https://doi.org/10.1038/nrendo.2011.128

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrendo.2011.128

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing